Human apolipoprotein(a) kringle V inhibits ischemia-induced retinal neovascularization via suppression of fibronectin-mediated angiogenesis

Diabetes

Volumn 61, Issue 6, 2012, Pages 1599-1608

  Lim, Yangmi ^a   Jo, Dong Hyun ^b,c   Kim, Jin Hyoung ^b   Ahn, Jin Hyung ^a   Hwang, Yu Kyeong ^a   Kang, Dong Ku ^d   Chang, Soo Ik ^d   Yu, Young Suk ^b,c   Yoon, Yeup ^a   Kim, Jeong Hun ^b,c  

^a Mogam Biotechnology Research Institute   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University   (South Korea)

^d Chungbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN KRINGLE V; COLLAGEN; FIBRONECTIN; FOCAL ADHESION KINASE; PROTEIN P130; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 3; VITRONECTIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL MIGRATION; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; FEMALE; FOCAL ADHESION; HUMAN; HUMAN CELL; ISCHEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RETINA NEOVASCULARIZATION; STRESS FIBER; TOXICITY TESTING;

ANIMALS; APOLIPOPROTEINS A; CELL MOVEMENT; ENDOTHELIAL CELLS; FIBRONECTINS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; PHOSPHORYLATION; RETINA; RETINAL NEOVASCULARIZATION;

EID: 84861870608     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1541     Document Type: Article

References (39)

1. Jo DH, Kim JH, Kim JH. How to overcome retinal neuropathy: the fight against angiogenesis-related blindness. Arch Pharm Res 2010;33:1557-1565
2. Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME. Vascular endothelial growth factor in eye disease. Prog Retin Eye Res 2008;27:331-371
3. Frank RN. Diabetic retinopathy. N Engl J Med 2004;350:48-58 (Pubitemid 38032183)
4. Badylak SF. The extracellular matrix as a scaffold for tissue reconstruction. Semin Cell Dev Biol 2002;13:377-383 (Pubitemid 35300815)
5. Casaroli Marano RP, Preissner KT, Vilaró S. Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy. Exp Eye Res 1995;60:5-17
6. George B, Chen S, Chaudhary V, Gonder J, Chakrabarti S. Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy. Curr Eye Res 2009;34:134-144
7. Probst K, Fijnheer R, Schellekens P, Rothova A. Intraocular and plasma levels of cellular fibronectin in patients with uveitis and diabetes mellitus. Br J Ophthalmol 2004;88:667-672 (Pubitemid 38526651)
8. Roy S, Cagliero E, Lorenzi M. Fibronectin overexpression in retinal microvessels of patients with diabetes. Invest Ophthalmol Vis Sci 1996;37: 258-266 (Pubitemid 26057051)
9. Cherian S, Roy S, Pinheiro A, Roy S. Tight glycemic control regulates fibronectin expression and basement membrane thickening in retinal and glomerular capillaries of diabetic rats. Invest Ophthalmol Vis Sci 2009;50:943-949
10. Kim JS, Yu HK, Ahn JH, et al. Human apolipoprotein(a) kringle V inhibits angiogenesis in vitro and in vivo by interfering with the activation of focal adhesion kinases. Biochem Biophys Res Commun 2004;313:534-540
11. Kim JS, Chang JH, Yu HK, et al. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a). J Biol Chem 2003;278:29000-29008
12. Cao Y, Cao R, Veitonmäki N. Kringle structures and antiangiogenesis. Curr Med Chem Anticancer Agents 2002;2:667-681 (Pubitemid 35175266)
13. Kim JH, Kim JH, Yu YS, Kim DH, Kim CJ, Kim KW. Establishment and characterization of a novel, spontaneously immortalized retinoblastoma cell line with adherent growth. Int J Oncol 2007;31:585-592
14. Lee TH, Kim MD, Shin SY, Lim HK, Seo JH. Disruption of hexokinase II (HXK2) partly relieves glucose repression to enhance production of human kringle fragment in gratuitous recombinant Saccharomyces cerevisiae. J Biotechnol 2006;126:562-567
15. Kang KY, Park JH, Lim IH, et al. Crystallization of antiangiogenic Kringle V derived from human apolipoprotein A: crystallization applied to purification and formulation. Biosci Biotechnol Biochem 2006;70:916-925
16. Kim JH, Kim JH, Yu YS, Shin JY, Lee HY, Kim KW. Deguelin inhibits retinal neovascularization by down-regulation of HIF-1alpha in oxygen-induced retinopathy. J Cell Mol Med 2008;12:2407-2415
17. Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994;35:101-111 (Pubitemid 24046832)
18. Min JK, Cho YL, Choi JH, et al. Receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice. Blood 2007;109:1495-1502
19. Kim JH, Kim JH, Yu YS, et al. Antiangiogenic effect of deguelin on choroidal neovascularization. J Pharmacol Exp Ther 2008;324:643-647
20. Lee Y, Lee EK, Cho YW, et al. ProteoChip: a highly sensitive protein microarray prepared by a novel method of protein immobilization for application of protein-protein interaction studies. Proteomics 2003;3:2289-2304 (Pubitemid 38010106)
21. Ausprunk DH, Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 1977;14:53-65 (Pubitemid 8153798)
22. Avraamides CJ, Garmy-Susini B, Varner JA. Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer 2008;8:604-617
23. Hutchings H, Ortega N, Plouët J. Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation. FASEB J 2003;17:1520-1522
24. Hynes RO. Cell-matrix adhesion in vascular development. J Thromb Haemost 2007;5(Suppl. 1):32-40 (Pubitemid 46964284)
25. Silva R, D'Amico G, Hodivala-Dilke KM, Reynolds LE. Integrins: the keys to unlocking angiogenesis. Arterioscler Thromb Vasc Biol 2008;28:1703-1713
26. Lee K, Yun ST, Kim YG, Yoon Y, Jo EC. Adeno-associated virus-mediated expression of apolipoprotein (a) kringles suppresses hepatocellular carcinoma growth in mice. Hepatology 2006;43:1063-1073 (Pubitemid 43724630)
27. Bishop PN. Vitreous as a substrate for vitreolysis. Dev Ophthalmol 2009;44:7-19
28. Seghieri G, Bartolomei G, De Giorgio LA. Plasma fibronectin in diabetic retinopathy and macroangiopathy. Diabete Metab 1986;12:186-190 (Pubitemid 16031140)
29. Wierzbicka-Patynowski I, Schwarzbauer JE. The ins and outs of fibronectin matrix assembly. J Cell Sci 2003;116:3269-3276 (Pubitemid 37038975)
30. Khan ZA, Chan BM, Uniyal S, et al. EDB fibronectin and angiogenesis - a novel mechanistic pathway. Angiogenesis 2005;8:183-196 (Pubitemid 41759143)
31. Deakin NO, Turner CE. Paxillin comes of age. J Cell Sci 2008;121:2435-2444
32. Arold ST, Hoellerer MK, Noble ME. The structural basis of localization and signaling by the focal adhesion targeting domain. Structure 2002;10:319-327 (Pubitemid 34230620)
33. Harburger DS, Calderwood DA. Integrin signalling at a glance. J Cell Sci 2009;122:159-163
34. Plow EF, Haas TA, Zhang L, Loftus J, Smith JW. Ligand binding to integrins. J Biol Chem 2000;275:21785-21788 (Pubitemid 30621742)
35. Tsuji T. Physiological and pathological roles of alpha3beta1 integrin. J Membr Biol 2004;200:115-132 (Pubitemid 39426112)
36. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-1487 (Pubitemid 24356306)
37. Schwartz MA. Integrin signaling revisited. Trends Cell Biol 2001;11:466-470 (Pubitemid 33079137)
38. Van Slambrouck S, Grijelmo C, De Wever O, et al. Activation of the FAK-src molecular scaffolds and p130Cas-JNK signaling cascades by alpha1-integrins during colon cancer cell invasion. Int J Oncol 2007;31:1501-1508
39. Schlaepfer DD, Jones KC, Hunter T. Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events. Mol Cell Biol 1998;18:2571-2585 (Pubitemid 28183427)